[Intranasal midazolam in pediatric ophthalmology].
Intranasal midazolam was tested in pediatric patients undergoing ophthalmological examination. 15 children aged 3.5 months to 10 years received 0.35-0.5 mg.kg-1 intranasal midazolam in association with a corneal anesthesia. The onset of sedation was rapid and permitted adequate ocular examination in all cases. In 8 of 15 cases where surgery followed immediately, the induction of inhalational anesthesia was easier. No local or general adverse reaction was noted. This non-invasive method of anesthesia may be compared to the intrarectal administration of midazolam, but the rapid onset of sedation and a cleaner route seem more suitable in surgical environment.
Gobeaux
D
D
Service d'Anesthésie-Réanimation, Fondation ophtalmologique A. de-Rothschild, Paris.
Sardnal
F
F
Cohn
H
H
Lequoy
O
O
D000281:Administration, Intranasal; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008874:Midazolam / Q000008:administration & dosage*; D009885:Ophthalmology / Q000379:methods*; D010372:Pediatrics
D008874:Midazolam
Midazolam intranasal en ophtalmologie pédiatrique.